PEEP FOR LUNG RECRUITMENT IN PRETERM INFANTS-EIT STUDY

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22-32
SponsorSouth Tees Hospitals NHS Foundation Trust

About this trial

Babies born early (under 32 weeks) are at risk of developing lung problems after birth. A major reason for this is that the lungs are not fully developed. Lungs of preterm babies will often collapse in between breathing due to lung immaturity. Applying gentle pressure, using nasal device through their nostril or through the breathing tube helps to prevent this lung collapse. This would help in air-oxygen going to lungs and also makes the babies breathing more comfortable. This gentle pressure is medically called as PEEP/CPAP and could be delivered by breathing machine (ventilator) and CPAP machine, collectively called as "continuous distending pressure (CDP)".

Those babies breathing on their own and receiving inadequate CDP would need more breathing support by placing them on breathing machine (ventilator). The longer the baby receives breathing machine support, higher chance of lung injury . Preterm infants who are already on breathing machine, providing sub optimal PEEP/CPAP could also lead to lung damage. Providing optimal PEEP/CPAP could prevent these negative outcomes. Currently there is not enough evidence to suggest optimal PEEP/CPAP in preterm infants. Neonatal units all around the world uses PEEP/CPAP ranging from 4 to 10cm H20 based on their unit practice. Currently available investigations provide limited one time information (e.g. Chest X-ray) regarding whether baby is receiving optimal PEEP/CPAP. Electrical Impedance Tomography (EIT) is a new technology which could provide better information regarding the pressure delivered. Also, this device would provide continuous information as if the clinicians are doing continuous chest X-ray but without any radiation. In this study, the team will assess the effect of different levels of PEEP/CPAP (4 to 10cm H20) on prevention of lung collapse using EIT. This would be studied in premature infants who are on breathing machine support and CPAP machine support.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Gestational age <32 weeks based on mother's last menstrual period or first trimester ultrasound dating.

Receiving either CPAP or mechanical ventilation respiratory support.

Informed written consent from one of the parents.

Within the first two weeks of life. Investigators pragmatically chose this period, as there could be considerable lung injury after the first two weeks of life, making it difficult to test our hypothesis. Also, this time period would allow parents to settle down with their stressful preterm delivery and investigators could approach anytime within the first two weeks of life.

Disqualifiers

Major congenital malformations including congenital lung disease and congenital heart disease as ascertained by the medical team.

Infants diagnosed with pneumothorax i.

Receiving high frequency mechanical ventilation.

Infants with concerns of skin integrity.

Trial design

Design model

Single group

Treatments tested in this trial

  • Studying the effects of varying levels of PEEP using Electrical impedance tomography

    Diagnostic test

    Feasibility of using EIT, to study the effect of varying levels of PEEP/Continous distending pressure on lung recruitment as measured by changes in functional lung scores and silent spaces in preterm infants (\<32 weeks) who are on mechanical ventilation or receiving primary or post extubation CPAP support.

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: Single arm with increasing and decreasing PEEP levelsExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Changes in EIT parameters

Changes in End expiratory Lung Impedance scores

Time frame
total study of 280 minutes
2

Changes in EIT parameters

Changes in functional lung scores in percentage varying levels of CDP.

Time frame
280minutes
3

Changes in EIT

Changes in silence spaces with varying levels of CDP.

Time frame
280 minutes

Secondary outcomes

1

Secondary outcomes

Changes in oxygen saturation (SpO2 in percentage) during the study period.

Time frame
Total 280 minutes of study time
2

Secondary outcome measure

Changes in carbon dioxide levels as measured by transcutaneous carbon dioxide levels (TCO2) in kilopascal.

Time frame
Total study time of 280 minutes
3

Secondary outcome

Changes in fraction of inspiratory oxygen (Fio2) levels during the study.

Time frame
Total study time of 280 minutes
4

Secondary outcome

Changes in blood pressure (if measured) during the study procedure.

Time frame
Total study time of 280minutes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.